Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

37.96
Delayed Data
As of 3:59pm ET
 -1.55 / -3.92%
Today’s Change
21.53
Today|||52-Week Range
41.20
+13.31%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 38.00, with a high estimate of 40.00 and a low estimate of 36.00. The median estimate represents a +0.11% increase from the last price of 37.96.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.78
Sales
$72.2M
Reporting Date
Nov 20

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 504.75%
 
 
 
 
 
Growthannually -29.28%
 
 
 
 
 
 

Sales

Growthquarterly 861.85%
 
 
 
 
 
 
Growthannually 12.35%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.